#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12558	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2016	609.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1413	1413	C	708	C,T	682,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12558	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2016	609.4	0	HET	.	.	.	C207T	.	207	207	C	436	436	C	687	C,T	514,148	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23586	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3636	640.1	0	.	n	.	0	T695C	SNP	695	695	T	1043	1043	C	723	C,T	702,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23586	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3636	640.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2319	2319	C	676	C,T	647,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23586	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3636	640.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2393	2393	A	738	A	710	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23586	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3636	640.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2945	2945	C	675	C,T	657,3	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1468	folP	855	855	100.0	folP.l15.c4.ctg.1	1557	93.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1002	1004	AGC	148;148;149	A;G;C	146;146;146	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4054	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3497	114.5	1	SNP	p	S91F	1	.	.	271	273	TTC	663	665	TTC	135;135;136	T;T;C	127;128;129	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4054	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3497	114.5	1	SNP	p	G95N	0	.	.	283	285	GGC	675	677	GGC	130;131;131	G;G;C	129;130;129	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4054	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3497	114.5	1	SNP	p	D95G	1	.	.	283	285	GGC	675	677	GGC	130;131;131	G;G;C	129;130;129	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1298	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1397	92.1	1	SNP	p	G45D	0	.	.	133	135	GGC	396	398	GGC	155;153;155	G;G;C	150;148;149	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	730	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1006	71.4	0	.	n	.	0	A197.	DEL	197	197	A	551	551	A	171	A	167	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3670	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2812	128.1	1	SNP	p	D86N	0	.	.	256	258	GAC	442	444	GAC	142;141;142	G;A,C;C	135;133,1;135	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3670	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2812	128.1	1	SNP	p	R87I	0	.	.	259	261	CGT	445	447	CGT	143;143;142	C,A;G;T	136,1;137;132	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3670	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2812	128.1	1	SNP	p	R87W	0	.	.	259	261	CGT	445	447	CGT	143;143;142	C,A;G;T	136,1;137;132	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3670	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2812	128.1	1	SNP	p	S87R	1	.	.	259	261	CGT	445	447	CGT	143;143;142	C,A;G;T	136,1;137;132	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3670	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2812	128.1	1	SNP	p	S88P	0	.	.	262	264	TCC	448	450	TCC	141;139;139	T;C;C,A	130;131;131,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3190	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2770	113.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1596	1598	GGC	163;159;159	G;G;C	158;153;154	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	152.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1251	1253	GCC	202;203;201	G;C,T;C	192;197,1;196	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	152.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1254	1256	ATG	202;198;198	A;T;G	196;194;193	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	152.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1266	1268	ACC	199;197;200	A;C;C	188;194;192	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	152.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1266	1268	ACC	199;197;200	A;C;C	188;194;192	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	152.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1767	1769	ACC	163;160;163	A;C;C	156;156;158	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	152.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1821	1823	GCG	153;152;149	G;C;G	151;149;146	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	152.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1821	1823	GCG	153;152;149	G;C;G	151;149;146	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	152.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1944	1946	GGT	131;129;128	G;G;T	129;125;126	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	152.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1953	1955	AGC	116;116;114	A;G;C	112;111;111	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2298	152.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1971	1973	CCG	93;94;96	C,G;C,G;G	80,4;85,1;87	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4876	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3133	153.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1579	1581	CCG	188;190;193	C,G;C;G,A	172,1;182;178,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1836	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1828	98.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	571	571	C	103	C,T	96,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2668	porB1b	1038	1038	99.04	porB1b.l15.c4.ctg.1	1614	163.2	0	.	p	.	0	E209_G210del	DEL	625	625	G	964	964	G	213	GG,GGAAGGATATG	199,3	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2668	porB1b	1038	1038	99.04	porB1b.l15.c4.ctg.1	1614	163.2	0	.	p	.	0	S217G	NONSYN	649	651	AGT	980	982	GGT	211;216;214	G,A;G;T	199,1;206;200	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2668	porB1b	1038	1038	99.04	porB1b.l15.c4.ctg.1	1614	163.2	1	SNP	p	G120K	1	.	.	358	360	AAG	698	700	AAG	228;232;234	A;A;G	218;228;221	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2668	porB1b	1038	1038	99.04	porB1b.l15.c4.ctg.1	1614	163.2	1	SNP	p	A121N	1	.	.	361	363	AAC	701	703	AAC	234;235;233	A;A;C,A	226;227;223,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2668	porB1b	1038	1038	99.04	porB1b.l15.c4.ctg.1	1614	163.2	1	SNP	p	N121D	0	.	.	361	363	AAC	701	703	AAC	234;235;233	A;A;C,A	226;227;223,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9236	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5012	181.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1148	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1097	103.1	1	SNP	p	V57M	1	.	.	169	171	ATG	585	587	ATG	224;225;220	A;T;G	215;214;213	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
